Differential HLA Gene Expression in Measles Vaccine Seropositive and Seronegative Subjects: A Pilot Study

References

• Clements CJ, Cutts FT. The epidemiology of measles: thirty years of vaccination. Curr Top Microbiol Immunol 1995; 191: 13–33.
   PubMed Web of Science ®Google Scholar
• Orenstein WA, Herrmann K, Albrecht P, Bernier R, Holmgreen P, Bart KJ, Hinman AR. Immunity against measles and rubella in Massachusetts schoolchildren. Dev Biol Standard 1986; 65: 75–83.
   PubMedGoogle Scholar
• Brunell PA, Weigle K, Murphy D, Shehab Z, Cobb E. Antibody response following measles–mumps rubella vaccine under conditions of customary use. JAMA 1983; 250: 1409–12.
   Google Scholar
• Centers for Disease Control and Prevention. Progress toward global measles control and regional elimination, 1990–1997 (Pamphlet). CDC; 1998. 47(48).
   Google Scholar
• Miller MA, Redd S, Hadler S, Hinman A. A model to estimate the potential economic benefits of measles eradication for the United States. Vaccine 1998; 16: 1917–22.
   PubMed Web of Science ®Google Scholar
• St. Sauver JL, Ovsyannikova IG, Jacobson RM, Jacobsen SJ, Vierkant RA, Schaid DJ, et al. Associations between human leukocyte antigen homozygosity and antibody levels to measles vaccine. J Infect Dis 2002; 185: 1545–9.
   PubMed Web of Science ®Google Scholar
• Poland GA. Variability in immune response to pathogens: using measles vaccine to probe immunogenetic determinants of response. Am J Hum Genet 1998; 62: 215–20.
   PubMed Web of Science ®Google Scholar
• Dhiman N, Bonilla R, O’Kane D, Poland GA. Gene expression microarrays: a 21st century tool for directed vaccine design. Vaccine 2001; 20: 22–30.
   Google Scholar
• Poland GA, Jacobson RM. The genetic basis for variation in antibody response to vaccines. Curr Opin Pediatr 1998; 10: 208–15.
   PubMed Web of Science ®Google Scholar
• Poland GA, Jacobson RM, Schaid DJ, Moore SB, Jacobsen SJ. The association between HLA class I alleles and measles vaccine-induced antibody response: evidence of a significant association. Vaccine 1998; 16: 1869–71.
   Google Scholar
• Poland GA, Ovsyannikova IG, Jacobson RM, Vierkant RA, Jacobsen SJ, Pankratz VS, Schaid DJ. Identification of an association between HLA class II alleles and low antibody levels after measles immunization. Vaccine 2001; 20: 430–8.
   Google Scholar
• Miller DM, Cebulla CM, Rahill BM, Sedmak DD. Cytomegalovirus and transcriptional down-regulation of major histocompatibility complex class II expression. Semin Immunol 2001; 13: 11–8.
   PubMed Web of Science ®Google Scholar
• Abendroth A, Slobedman B, Lee E, Mellins E, Wallace M, Arvin AM. Modulation of major histocompatibility class II protein expression by varicella-zoster virus. J Virol 2000; 74: 1900–7.
   PubMed Web of Science ®Google Scholar
• Saifuddin M, Spear GT, Chang C, Roebuck KA. Expression of MHC class II in T cells is associated with increased HIV-1 expression. Clin Exp Immunol 2000; 121: 324–31.
   PubMed Web of Science ®Google Scholar
• Leopardi R, Ilonen J, Mattila L, Salmi AA. Effect of measles virus infection on MHC class II expression and antigen presentation in human monocytes. Cell Immunol 1993; 147: 388–96.
   PubMed Web of Science ®Google Scholar
• Talary MS, Burt JP, Pethig R. Future trends in diagnosis using laboratory-on-a-chip technologies. Parasitology 1998; 117: S191–203.
   Google Scholar
• Kurian KM, Watson CJ, Wyllie AH. DNA chip technology. J Pathol 1999; 187: 267–71.
   PubMed Web of Science ®Google Scholar
• Watson SJ, Meng F, Thompson RC, Akil H. The ‘chip’ as a specific genetic tool. Soc Biol Psychiatry 2000; 48: 1147–56.
   PubMed Web of Science ®Google Scholar
• Gerhold D, Rushmore T, Caskey CT. DNA chips: promising toys have become powerful tools. Trends Biochem Sci 1999; 24: 168–73.
   Google Scholar
• Manger ID, Relman DA. How the host ‘sees’ pathogens: global gene expression responses to infection. Curr Opin Immunol 2000; 12: 215–8.
   PubMed Web of Science ®Google Scholar
• Cummings CA, Relman DA. Using DNA microarrays to study host-microbe interactions. Genomics 2000; 6: 513–24.
   Google Scholar
• Wilgenbus KK, Lichter P. DNA chip technology ante portas. J Mol Med 1999; 77: 761–8.
   PubMed Web of Science ®Google Scholar
• Geiss GK, Bumgarner RE, An MC, Agy MB, van’t Wout AB, Hammersmark E, et al. Large-scale monitoring of host cell gene expression during HIV-1 infection using cDNA microarrays. Virology 2000; 266: 8–16.
   Google Scholar
• Stingley SW, Ramirez JJ, Aguilar SA, Simmen K, Sandri-Goldin RM, Ghazal P, Wagner EK. Global analysis of herpes simplex virus type 1 transcription using an oligonucleotide-based DNA microarray. J Virol 2000; 74: 9916–27.
   Google Scholar
• Affymetrix: Statistical algorithms description document. http://www.affymetrix.com/support/technical/whitepapers/sadd_whitepaper.pdf (online). Santa Clara, CA: Affymetrix; 2002.
   Google Scholar
• Dhiman N, Ovsyannikova IG, Pinsky N, Vierkant RA, Jacobson RM, Poland GA. The association of TAP1 and TAP2 polymorphisms and antibody response to live measles vaccine virus (Abstract). 4th Annual Conference on Vaccine Research; 2001. P43:72.
   Google Scholar
• Kruskall MS, Alper CA, Awdeh Z, Yunis EJ, Marcus-Bagley D. The immune response to hepatitis B vaccine in humans: inheritance patterns in families. J Exp Med 1992; 175: 495–502.
   Google Scholar
• Davenport MP, Quinn CL, Chicz RM, Green BN, Willis AC, Lane WS, et al. Naturally processed peptides from two disease-resistance-associated HLA-DR13 alleles show related sequence motifs and the effects of the dimorphism at position 86 of the HLA-DRβ chain. Proc Natl Acad Sci USA 1995; 92: 6567–71.
   PubMed Web of Science ®Google Scholar
• Stachowski J, Kramer J, FUst G, Maciejewski J, Baldmus CA, Petranyi GG. Relationship between the reactivity to hepatitis B virus vaccination and the frequency of MHC class I, II and III alleles in haemodialysis patients. Scand J Immunol 1995; 42: 60–5.
   PubMed Web of Science ®Google Scholar
• Suzuki T, Yamauchi K, Kuwata T, Hayashi N. Characterization of hepatitis B virus surface antigen-specific CD4+ T cells in hepatitis B vaccine non-responders. J Gastroenterol Hepatol 2001; 16: 898–903.
   PubMed Web of Science ®Google Scholar
• Hohler T, Gerken G, Notghi A, Knolle P, Lubjuhn R, Taheri H, et al. MHC class II genes influence the susceptibility to chronic active hepatitis C. J Hepatol 1997; 27: 259–64.
   PubMed Web of Science ®Google Scholar
• Pabst HF, Spady DW Carson MM, Stelfox HT, Beeler JA, Krezolek MP Kinetics of immunologic responses after primary MMR vaccination. Vaccine 1997; 15: 10–4.
   PubMed Web of Science ®Google Scholar
• Gans H, Yasukawa L, Rinki M, DeHovitz R, Forghani B, Beeler J, et al. Immune responses to measles and mumps vaccination of infants at 6, 9, and 12 months. J Infect Dis 2001; 184: 817–26.
   PubMed Web of Science ®Google Scholar
• Nanan R, Carstens C, Kreth HW. Demonstration of virus-specific CD8⁺ memory T cells in measles-seropositive individuals by in vitro peptide stimulation. Clin Exp Immunol 1995; 102: 40–5.
   Google Scholar
• Bautista-Lopez N, Ward BJ, Mills E, McCormick D, Martel N, Ratnam S. Development and durability of measles antigen-specific lymphoproliferative response after MMR vaccination. Vaccine 2000; 18: 1393–401.
   Google Scholar